Atypical neurogenesis in induced pluripotent stem cell (iPSC) from autistic individuals
Dwaipayan AdhyaiD, Vivek SwarupiD, Roland NagyiD, Lucia Dutan PolitiD, Carole Shum, Eva P. Valencia-AlarcóniD, Kamila Maria JozwikiD, María Andreina MéndeziD, Jamie HorderiD, Eva LothiD, Paulina Nowosiad, Irene LeeiD, David SkuseiD, Frances A. Flinter, Declan MurphyiD, Grainne Mary McAlonaniD, Daniel H. GeschwindiD, Jack PriceiD, Jason S. CarrolliD, Deepak P. SrivastavaiD, Simon Baron‐CoheniD
Abstract
BackgroundAutism is a heterogenous collection of disorders with a complex molecular underpinning. Evidence from post-mortem brain studies using adult brains have indicated that early prenatal development may be altered in autism. Induced pluripotent stem cells (iPSCs) generated from autistic individuals with macrocephaly also indicate prenatal development as a critical period for this condition. But little is known about early altered cellular events during prenatal stages in autism. MethodsIPSCs were generated from 9 unrelated autistic individuals without macrocephaly and with heterogeneous genetic backgrounds, and 6 typically developing, control, individuals. IPSCs were differentiated towards either cortical or midbrain fates. Gene expression and high throughput cellular phenotyping was used to characterise iPSCs at different stage of differentiation. ResultsA subset of autism-iPSC cortical neurons were RNA-sequenced to reveal autism-specific signatures similar to post-mortem brain studies, indicating a potential common biological mechanism. Autism-iPSCs differentiated towards a cortical fate displayed impairments in the ability to self-form into neural rosettes. In addition, autism-iPSCs demonstrated significant differences in rate of cell type assignment of cortical precursors, and dorsal and ventral forebrain precursors. These cellular phenotypes occurred in the absence of alterations in cell proliferation during cortical differentiation, differing from previous studies. Acquisition of cell fate during midbrain differentiation was not different between control- and autism-iPSCs. ConclusionsTaken together, our data indicate that autism-iPSCs diverge from control-iPSCs at a cellular level during early stage of neurodevelopment. This suggests that unique developmental differences associated with autism may be established at early prenatal stages.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 66
- FWCI
- 3.08
- Field percentile
- top 7%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Autism-specific PTEN p.I135L mutation and an autism genetic background combine to dysregulate cortical neurogenesis
Shuai Fu, Luke A. D. Bury, … Anthony J. Wynshaw-Boris·The American Journal of Human GeneticsPeer-reviewed·Apr 24, 2023
- Cellular and molecular characterization of multiplex autism in human induced pluripotent stem cell-derived neurons
Emily M. A. Lewis, Kesavan Meganathan, … Kristen L. Kroll·Molecular AutismPeer-reviewed·Dec 1, 2019
- CNTN5-/+ or EHMT2-/+ iPSC-Derived Neurons from Individuals with Autism Develop Hyperactive Neuronal Networks
Éric Deneault, Muhammad Faheem, … Stephen W. Scherer·eLifePeer-reviewed·Feb 11, 2019
- Early maturation and hyperexcitability is a shared phenotype of cortical neurons derived from different ASD-associated mutations
Yara Hussein, Utkarsh Tripathi, … Shani Stern·Translational PsychiatryPeer-reviewed·Jul 6, 2023
- CHD8 regulates the balance between proliferation and differentiation of human iPSCs in neural development
Wenzhong Liu, Weilai Dong, … Abha R. Gupta·bioRxiv·Aug 13, 2019
- Differentiation of human induced pluripotent stem cells into cortical neural stem cells
Alexandra S. Neaverson, Malin H. L. Andersson, … Sebastian S. Gerety·Frontiers in Cell and Developmental BiologyPeer-reviewed·Jan 5, 2023